Position in EYPT
as of Jun 30, 2026
· filed Aug 26, 2026
Position Value
$9,294,199
+$1,124,982 QoQ
Shares Held
649,944
+2.6% QoQ
Ownership
0.754%
of shares outstanding
% of Portfolio
13.57%
of 13F equity value
Holder Rank
#32
of 188 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in EYPT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Principia Wealth Advisory, LLC holds $14,097,964 across 26 Biotechnology names. EYPT ranks #1 (65.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EYPT |
EyePoint, Inc.
This page
|
649,944 | $9,294,199 | |
| 2 | OCUL |
Ocular Therapeutix, Inc
|
440,618 | $4,326,868 | |
| 3 | VKTX |
Viking Therapeutics, Inc.
|
6,478 | $252,706 | |
| 4 | INCY |
Incyte Corp
|
1,524 | $172,760 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
29 | $14,405 | |
| 6 | ATAI |
AtaiBeckley Inc.
|
2,000 | $10,540 | |
| 7 | ARGX |
Argenx SE
|
5 | $4,638 | |
| 8 | RPRX |
Royalty Pharma plc
|
57 | $3,195 |
All Filings in EYPT
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,294,199 | 649,944 | Shares | Sole | 2026-08-26 | |
| 2026-03-31 | $8,169,217 | 633,764 | Shares | Sole | 2026-08-26 | |
| 2025-12-31 | $9,696,345 | 530,725 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $7,557,524 | 530,725 | Shares | Sole | 2026-02-10 | |
| 2025-06-30 | $5,022,850 | 533,778 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $2,893,076 | 533,778 | Shares | Sole | 2025-04-11 | |
| 2024-12-31 | $2,014,345 | 270,382 | Shares | Sole | 2025-04-11 | |
| No filing history on record for this holder in this stock. | ||||||